Snider James William, Datta Niloy Ranjan, Vujaskovic Zeljko
a Department of Radiation Oncology , University of Maryland Medical Center , Baltimore , Maryland , USA ;
b Department of Radiation Oncology, KSA-KSB, Kantonsspital Aarau , Aarau , Switzerland.
Int J Hyperthermia. 2016 Jun;32(4):398-406. doi: 10.3109/02656736.2016.1150524. Epub 2016 Apr 20.
Hyperthermia represents a unique, safe, and advantageous methodology for improving therapeutic strategies in the management of bladder cancer. This modality has shown promise in contributing to treatment regimens for both superficial and muscle-invasive disease. Especially in conjunction with intravesical chemotherapy, systemic therapy, and radiotherapy, hyperthermia shows particular synergistic benefit. As such, it should be explored further through clinical use and clinical trial in conjunction with currently available techniques and emerging technologies. However, to conceptualise the way forward, it is particularly important to understand the current challenges to widespread use of non-invasive, bladder-sparing approaches and the current state of bladder cancer care. As such, in the following article, we have focused on not only the rationale for concurrent radiotherapy and hyperthermia, but also the clinical landscape in bladder cancer as a whole.
热疗是一种独特、安全且具有优势的方法，可用于改善膀胱癌治疗策略。这种治疗方式在浅表性和肌层浸润性疾病的治疗方案中已显示出前景。特别是与膀胱内化疗、全身治疗和放疗联合使用时，热疗显示出特别的协同效益。因此，应结合当前可用技术和新兴技术，通过临床应用和临床试验进一步探索热疗。然而，为了构想未来的发展方向，了解非侵入性、保留膀胱方法广泛应用的当前挑战以及膀胱癌护理的现状尤为重要。因此，在以下文章中，我们不仅关注同步放疗和热疗的基本原理，还关注整个膀胱癌的临床情况。
